The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.
The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday.
The drug, marketed as Bixlenvo, is aimed… [+6607 chars]
The drug, marketed as Bixlenvo, is aimed… [+6607 chars]